BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7384549)

  • 1. Vasoactive intestinal polypeptide (VIP) inhibits prostaglandin-F2 alpha-induced activity of the rabbit myometrium.
    Ottesen B; Wagner G; Fahrenkrug J
    Prostaglandins; 1980 Mar; 19(3):427-35. PubMed ID: 7384549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vasoactive intestinal polypeptide (VIP) upon myometrial blood flow in non-pregnant rabbit.
    Ottesen B; Fahrenkrug J
    Acta Physiol Scand; 1981 Jun; 112(2):195-201. PubMed ID: 7315413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal polypeptide (VIP) inhibits oxytocin induced activity of the rabbit myometrium.
    Ottesen B; Ulrichsen H; Wagner G; Fahrenkrug J
    Acta Physiol Scand; 1979 Nov; 107(3):285-87. PubMed ID: 539459
    [No Abstract]   [Full Text] [Related]  

  • 4. Vasoactive intestinal polypeptide (VIP): effect on rabbit uterine smooth muscle in vivo and in vitro.
    Ottesen B
    Acta Physiol Scand; 1981 Oct; 113(2):193-9. PubMed ID: 6947684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of VIP in the female genital tract.
    Ottesen B; Fahrenkrug J; Wagner G; Ulrichsen H; Einer-Jensen N; Carter AM; Larsen JJ; Stolberg B
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():71-8. PubMed ID: 7227322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of vasoactive intestinal polypeptide (VIP) on histamine or prostaglandin F-2alpha-induced bronchoconstriction (author's transl)].
    Hara N; Yosida T; Said SI
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Dec; 16(11):840-5. PubMed ID: 739695
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of action of vasoactive intestinal polypeptide on myometrial smooth muscle of rabbit and guinea-pig.
    Bolton TB; Lang RJ; Ottesen B
    J Physiol; 1981 Sep; 318():41-55. PubMed ID: 7320897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased myometrial blood flow evoked by vasoactive intestinal polypeptide in the non-pregnant goat.
    Carter AM; Einer-Jensen N; Fahrenkrug J; Ottesen B
    J Physiol; 1981 Jan; 310():471-80. PubMed ID: 7230045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin.
    Williams TJ
    Br J Pharmacol; 1982 Nov; 77(3):505-9. PubMed ID: 6958342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of NPY and VIP in regulation of myometrial blood flow and mechanical activity.
    Tenmoku S; Ottesen B; O'Hare MM; Sheikh S; Bardrum B; Hansen B; Walker B; Murphy RF; Schwartz TW
    Peptides; 1988; 9(2):269-75. PubMed ID: 3375135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vasoactive intestinal polypeptide (VIP) on the in vitro and in vivo motility of the rabbit reproductive tract.
    Fredericks CM; Ashton SH
    Fertil Steril; 1982 Jun; 37(6):845-50. PubMed ID: 7084506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and motor effect of VIP in female genital tract.
    Ottesen B; Larsen JJ; Fahrenkrug J; Stjernquist M; Sundler F
    Am J Physiol; 1981 Jan; 240(1):E32-6. PubMed ID: 7006413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal polypeptide and the female genital tract: relationship to reproductive phase and delivery.
    Ottesen B; Ulrichsen H; Fahrenkrug J; Larsen JJ; Wagner G; Schierup L; Søndergaard F
    Am J Obstet Gynecol; 1982 Jun; 143(4):414-20. PubMed ID: 7201240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VIP nerve fibres around peripheral blood vessels.
    Uddman R; Alumets J; Edvinsson L; Håkanson R; Sundler F
    Acta Physiol Scand; 1981 May; 112(1):65-70. PubMed ID: 7282406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vasoactive intestinal polypeptide on uterine blood flow in pregnant ewes.
    Clark KE; Austin JE; Stys SJ
    Am J Obstet Gynecol; 1982 Nov; 144(5):497-502. PubMed ID: 7137236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and dilatory effect of vasoactive intestinal polypeptide (VIP) in human cerebral arteries.
    Edvinsson L; Ekman R
    Peptides; 1984; 5(2):329-31. PubMed ID: 6382196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vasoactive intestinal peptide and pancreatic polypeptide in rabbit intestine.
    Camilleri M; Cooper BT; Adrian TE; Bloom SR; Chadwick VS
    Gut; 1981 Jan; 22(1):14-8. PubMed ID: 6257593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal polypeptide as a neurotransmitter in the female genital tract.
    Ottesen B
    Am J Obstet Gynecol; 1983 Sep; 147(2):208-24. PubMed ID: 6137145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of vasoactive intestinal polypeptide (VIP) in the neurogenic vasodilatation of the portal vein in the rabbit.
    Hellstrand P; Fahrenkrug J; Uddman R; Järhult J
    Regul Pept; 1985 Nov; 12(4):309-16. PubMed ID: 3911302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vasoactive intestinal polypeptide upon ovarian steroids, ovum transport and fertility in the rabbit.
    Fredericks CM; Lundquist LE; Mathur RS; Ashton SH; Landgrebe SC
    Biol Reprod; 1983 Jun; 28(5):1052-60. PubMed ID: 6871308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.